1,3,8-triazaspiro[4,5]decan-4-one derivatives

Details 1,3,8-triazaspiro[4,5]decan-4-one derivatives 1,3,8-triazaspiro[4,5]decan-4-one derivatives

1998-01-20

2000-06-06

Shah, Mukund J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

546 20, A61K 31445, C07D21198

Patent

active

060719257

ABSTRACT:
The present invention relates to compounds of the formula ##STR1## wherein R.sup.1 and R.sup.2 are each independently hydrogen, lower alkyl, lower alkoxy or halogen;

REFERENCES:
patent: 4076821 (1978-02-01), Tsuda et al.
patent: 4160836 (1979-07-01), Vandenberx et al.
patent: 4329353 (1982-05-01), Stokbroekx et al.
patent: 4707484 (1987-11-01), Berger et al.
patent: 4880802 (1989-11-01), Schohe et al.
patent: 5026857 (1991-06-01), Schohe et al.
patent: 5039804 (1991-08-01), Feldman et al.
patent: 5153225 (1992-10-01), Schohe et al.
patent: 5298513 (1994-03-01), Schohe et al.
patent: 5463105 (1995-10-01), Schohe et al.
Derwent Abstract, DE 4405178.
Derwent Abstract, EP 539 803.
Bunzow, James R., et al., FEBS Letters, 347:284-288 (1994).
Cheng, Yung-Chi and William H. Prusoff, Biochem. Pharmacol, 22:3099-3108 (1973).
Julius, David, Nature, 377:476 (1995).
Mattson, Ronald J., et al., J. Org. Chem., 55:2552-2554 (1990).
Mavunkel, Babu J., et al., J. Med. Chem., 39:3169-3173 (1996).
Tschaen, David M., et al., J. Org. Chem., 60:4324-4330 (1995).

Affiliated with

Also associated with

Rating

1,3,8-triazaspiro[4,5]decan-4-one derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1,3,8-triazaspiro[4,5]decan-4-one derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,3,8-triazaspiro[4,5]decan-4-one derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2213845